<i>B-MOBILE</i> - A Smartphone-Based Intervention to Reduce Sedentary Time in Overweight/Obese Individuals: A Within-Subjects Experimental Trial by Dale S. Bond (588506)

“…Average % SED at baseline (72.2%) decreased by 5.9%, 5.6%, and 3.3% [i.e. by mean (95% CI) −47.2(−66.3, −28.2), −44.5(−65.2, −23.8), and −26.2(−40.7, −11.6) min/d] in the 3-, 6-, and 12-min conditions, respectively. …”

Overexpression or deletion of <i>eIF2A</i> has no effect on the transcriptome compared to the wild-type strain. by Laura Meyer (4033793)

Glucagon receptor (GcgR) antagonism decrease α-cell proliferation. by Zhuo Liu (357070)

Topical HPMC/S-Nitrosoglutathione Solution Decreases Inflammation and Bone Resorption in Experimental Periodontal Disease in Rats - Fig 2 by Conceição S. Martins (468492)

A Single-Nucleotide Polymorphism of Human Neuropeptide S Gene Originated from Europe Shows Decreased Bioactivity by Cheng Deng (416051)

Data for predator-induced defense decreases growth rate and photoprotective capacity in a nitrogen-limited dinoflagellate by Jingjing Zhang (17584605)

CXCR4 blockade decreased the percentage of PD-1 expressing adaptive immune cells in sepsis. by Kimberly M. Ramonell (4678906)

“…<p><b>(A-B)</b> Representative flow plots (gated on CD3 cells) demonstrating PD-1 expression in CD4⁺ T cells and CD8⁺ T cells. …”

5-Aza-2-deoxycytidine (5-Aza-dC) treatment does not affect methylation status of the CpG islands near to putative promoter region of both genes. by Bruna Rodrigues Muys (2588305)

YTX treatment decreases tumour development in the B16F10 melanoma mouse model. by Araceli Tobío (3545306)

Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene by Muhammad Idrees (92773)

Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene by Muhammad Idrees (92773)

E2 and DPN decrease p65 occupancy and Ac-H4 levels. by Winfred Stacey (3097896)

Supplementary Material for: Macrolide Therapy Decreases Chronic Obstructive Pulmonary Disease Exacerbation: A Meta-Analysis by Yao G.-Y. (4139125)

Expression of Egln3 decreases tumor aggression, increases survival and normalizes glioma vascular architecture. by Vicki A. Sciorra (312082)

CF-BECs demonstrate little change in viability after infection with PA at a dilution of 2 x 10² the OD 0.5 after 24 hours. by Meghan J. Hirsch (16528311)

NG2 knockdown in GBM xenografts increased vascular reabsorption, decreased plasma volume and normalized tumour vasculature. by Jian Wang (5901)

Blocking C5L2 decreased MPO concentration in the supernatant of C5a-primed neutrophils. by Jian Hao (160736)

Expression of human PON1 decreases superoxide levels in the gut of <i>D. melanogaster</i>. by Alejandro A. Pezzulo (138238)

P63 and CD44 expression were decreased in triple mutants. by Kyung-Suk Choi (162073)

“…Np63 was expressed in the AER and epithelial cells of E10.5 and E11.5 control (A and C) and triple mutant hindlimbs (B and D). …”

Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice. by Milena Jović (6707702)

“…(E-H) In the FO-treated 5xFAD animals the decreased surface of the Aβ halo overlaps with the decreased incidence of swollen, dystrophic neurites.…”